Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Pfizer's CD3 bispecific to compete with CAR -T therapy

View:

Post by Noteable on Jul 28, 2023 11:47pm

Pfizer's CD3 bispecific to compete with CAR -T therapy

https://www.pfizer.com/news/press-release/press-release-detail/pfizers-elranatamab-receives-fda-and-ema-filing-acceptance

257

Comment

Comment by westcoast1000 on Jul 29, 2023 10:55am

Quoting Noteable, from Oct 2022, who was quoting a paper citing respected investigators: Reovirus + CD3 bispecific combination .... "a true tumor-killer combo that would not be effective without each other." according to the investigators who undertook the bispecific combination study.

152

Comment

Comment by Noteable on Jul 29, 2023 11:26am

Pfizer's elranatamab, is an investigational B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody (BsAb), for the treatment of patients with relapsed or refractory multiple myeloma (RRMM), a liquid (blood) cancer. ONCY's involvement with Dr. Richard Vile of the Mayo Clinic involves the use of CAR-T + pelareorep in solid tumors, where applications are significantly ...more

120

Comment

Oncolytics Biotech Inc